Effects of extracorporeal shock wave lithotripsy on tiered therapy implantable cardioverter defibrillators.
The effects of extracorporeal shock wave lithotripsy (ESWL) were tested on four advanced generation implantable cardioverter-defibrillators (ICDs) in vitro and in vivo in two patients. During in vitro testing, advancement of nonsustained episode counters occurred in one device, and a set screw and power source cell loosened in another, which was connected to an external power source. No arrhythmias occurred during in vivo procedures, but programmed parameters were reset and elective replacement indicated after one procedure. ESWL can be performed safely in selected patients with ICDs, but testing should be performed afterwards to confirm satisfactory function and component continuity.
Chung
M K
MK
Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA. chungm@cesmtp.ccf.org
Streem
S B
SB
Ching
E
E
Grooms
M
M
Mowrey
K A
KA
Wilkoff
B L
BL
D017147:Defibrillators, Implantable; D004562:Electrocardiography; D005500:Follow-Up Studies; D006801:Humans; D007669:Kidney Calculi / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D017180:Tachycardia, Ventricular / Q000150:complications / Q000628:therapy*; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000628:therapy*